Human cholangiocarcinomas express somatostatin receptors and respond to somatostatin with growth inhibition

Gastroenterology

Volumn 108, Issue 6, 1995, Pages 1908-1916

  Chee Kiat Tan, ^a   Podila, Prasad V ^a   Taylor, John E ^b   Nagorney, David M ^a   Wiseman, Gregory A ^a   Gores, Gregory J ^a   Larusso, Nicholas F ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b Biomeasure Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANGIOPEPTIN; CALCIUM; CYCLIC AMP; DISOFENIN; DISOFENIN TC 99M; MESSENGER RNA; OCTREOTIDE; PENTETREOTIDE IN 111; SECRETIN; SEGLITIDE; SOMATOSTATIN; SOMATOSTATIN 14; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ADULT; AGED; ANIMAL MODEL; ARTICLE; BILE DUCT CARCINOMA; CANCER HORMONE THERAPY; CANCER INHIBITION; CANCER LOCALIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029078040     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(95)90157-4     Document Type: Article

References (48)

1. Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications
2. Somatostatin receptor subtype gene expression in human and rodent tumors
3. Somatostatin-containing cells in the extrahepatic biliary tract of humans
4. Bile duct ligation upregulates the message for the somatostatin receptor in intrahepatic bile duct epithelial cells: implications for somatostatin-induced ductular cholestasis
5. Neuroendocrine differentiation and prognosis of extrahepatic biliary tract carcinomas
6. SMS 201.995 inhibits in vitro and in vivo growth of human colon cancer
7. Antiproliferative effects of somatostatin and the somatostatin analog SMS 201-995 on three human breast cancer cell lines
8. 3) proliferation in vitro
9. In vitro and in vivo inhibition of human small cell lung carcinoma (NCI-H69) growth by a somatostatin analogue
10. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase
11. Biliary adenocarcinoma—characterization of three new human tumor cell lines
12. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney
13. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
14. Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation
15. Distribution and abundance of neutral endopeptidase (EC 3.4.24.11) in the alimentary tract of the rat
16. 11]-somatostatin-14 to human small cell lung carcinoma (NCI-H69)
17. An improved colorimetric assay for interleukin 2
18. Treatment of R-3327 prostate tumors with a somatostatin analogue (somatuline) as adjuvant therapy following surgical castration
19. Effect of somatostatin analog RC-160 and Bombesin/Gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice
20. Inhibitory effects of somatostatin analogue RC-160 and bombesin gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent dunning R-3327-AT-1 rat prostate cancer
21. Improved microfluorometric DNA determination in biological material using 33258 Hoechst
22. Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes
23. Treatment with Sandostatin and in vivo localization of tumors with radiolabeled somatostatin analogs
24. The visualization of gastroenteropancreatic endocrine tumors
25. Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylcyclase
26. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype
27. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization
28. Somatostatin receptors (SS-R) are expressed and correlate with prognosis in childhood neuroblastoma
29. Prognostic value of receptors for insulin-like growth factor-I, somatostatin and epidermal growth factor in human breast cancer
30. Mechanisms of action of long-acting analogs of somatostatin
31. Inhibitory effect of a somatostatin analogue (SMS 201-995) on the growth of androgen-dependent mouse mammary tumor (Shionogi carcinoma 115)
32. Evaluation of receptors for somatostatin in various tumors using different analogs
33. Effect of somatostatin and its analogue on proliferation of human epidermoid carcinoma cells in vitro
34. Octreotide (SMS 201-995) inhibits the growth of colon peritoneal carcinomatosis in BDIX rats
35. Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin
36. Studies on the mechanism of action of the inhibitory effect of the somatostatin analog SMS 201-995 on the growth of the prolactin/adrenocorticotropin-secreting pituitary tumor 7315a
37. Partial inhibition of the growth of transplanted Dunning rat prostate tumors with the long-acting somatostatin analogue Sandostatin
38. Desensitization and resensitization of rat pituitary tumor cells in long-term culture to the effects of the somatostatin analogue SMS 201-995 on cell growth and prolactin
39. 1 pituitary cell membranes
40. The rat SSTR2 somatostatin receptor subtype is coupled to inhibition of cyclic AMP accumulation
41. Cyclic AMP: a mitogenic signal for Swiss 3T3 cells
42. Prolonged somatostatin pretreatment desensitizes somatostatin's inhibition of receptor-mediated release of adrenocorticotropin hormone and sensitizes adenylate cyclase
43. The regulation of mitotic spindle function
44. Somatostatin blocks a calcium current in rat sympathetic ganglion neurones
45. Somatostatin inhibits rapid centrosomal separation and cell proliferation induced by epidermal growth factor
46. Inhibition of gastrin-stimulated growth of gastrointestinal tumour cells by octreotide and the gastrin/cholecystokinin receptor antagonists, proglumide and lorglumide
47. Selective suppression of insulin-induced proliferation of cultured human hepatoma cells by somatostatin
48. Somatostatin analog: an inhibitor of angiogenesis